3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Infectious Mononucleosis
1
Epstein-Barr Virus Infections
1
Interventions
Rituximab
7
Valganciclovir
5
Valacyclovir
3
Gemcitabine
3
Dexamethasone
3
Cisplatin
3
spartalizumab
2
pegaspargase
2
Radiotherapy, Intensity-Modulated
2
Methylprednisolone
2
Lenalidomide
2
Etoposide
2
Doxorubicin
2
Cell Count
2
Blood Specimen Collection
2
valomaciclovir
1
toripalimab
1
ruxolitinib
1
pembrolizumab
1
merphos
1
fludarabine
1
dehydroftorafur
1
avelumab
1
apatinib
1
Zidovudine
1
Watchful Waiting
1
Valproic Acid
1
Vaccines
1
Tenofovir
1
Tegafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epstein-Barr Virus Infections
×
valomaciclovir
×
Clear all
NCT00575185
2017-03-22
Mono6
University of Minnesota
Phase 1/2
Completed
23 enrolled
8 charts